Candel Therapeutics Inc (CADL) — Cash Flow Quality Index

Latest as of March 2025: -1.17x

Candel Therapeutics Inc (CADL) has a Cash Flow Quality Index of -1.17x as of March 2025. Operating cash flow of $-8.62 Million is below net income of $7.38 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Candel Therapeutics Inc asset portfolio for the complete picture of this company's asset base.

Cash Flow Quality Index

-1.17x

Operating CF / Net Income

Operating Cash Flow

$-8.62 Million

USD

Net Income

$7.38 Million

USD

Data as of

Mar 2025

Most recent filing

Annual Cash Flow Quality Index for Candel Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Candel Therapeutics Inc. For live market cap and the full company financial profile, see market cap of Candel Therapeutics Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.